| This Week’s News | Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. | | |
| Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. | | |
| The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology. The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology. | | |
| According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. | | |
| The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions. The 3D-printed models are soft, flexible and can mimic the way a patient's heart may respond to different interventions. | | |
| The report, developed by Abbott, examined everything from AI to social determinants of health. One key finding was that patients grade their overall satisfaction with a physician or hospital based on much more than the effectiveness of their treatment. The report, developed by Abbott, examined everything from AI to social determinants of health. One key finding was that patients grade their overall satisfaction with a physician or hospital based on much more than the effectiveness of their treatment. | | |
| Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more. Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more. | | |
| The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies. The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies. | | |
| |
|
| ![]() | |
|
